Episode 4 of Gray Areas features a conversation with Rammohan R. Sankaraneni, MBBS, of Allina Health, examining the real scope of AI's impact on neurology, from stroke workflows and EEG monitoring to the unanswered questions that will define where the technology goes next.
Episode 3 of Gray Areas features a conversation with KuangHua Guo, MD, PhD, discussing the evolving debate around whether sleep disorders directly cause neurodegenerative disease and what the current evidence actually shows.
Episode 2 of Gray Areas features a conversation with Brian Callaghan, MD, MS, professor of neurology at the University of Michigan, discussing the clinical debate around whether diabetic peripheral neuropathy is reversible if diagnosed and treated early enough.
Episode 1 features a conversation with Ahmet Hoke, MD, PhD, of Johns Hopkins Medicine, discussing the clinical debate behind keeping animal models for neuropathy research vs switching to induced pluripotent stem cell models.
